Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Sunmi Jo"'
Autor:
Sunmi Jo, Jaewan Jeon, Geumju Park, Hwan-Kwon Do, JiHoon Kang, Ki Jung Ahn, Sun Young Ma, Young Min Choi, Donghyun Kim, BuHyun Youn, Yongkan Ki
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 5, p 2757 (2024)
The “oxygen effect” improves radiation efficacy; thus, tumor cell oxygen concentration is a crucial factor for improving lung cancer treatment. In the current study, we aimed to identify aerobic exercise-induced changes in oxygen concentrations i
Externí odkaz:
https://doaj.org/article/738c31ee957c4917a4c743afcb03eb4c
Publikováno v:
Cancers, Vol 15, Iss 20, p 4914 (2023)
Intensity-modulated radiotherapy (IMRT), an advanced RT technique, is a considerable treatment option for hepatocellular carcinoma (HCC). However, the distinguishing features of IMRT for HCC have not yet been clearly defined. A systematic review was
Externí odkaz:
https://doaj.org/article/bd7f3e1a2fb64d329120d11a24324119
Autor:
Seokmo Lee MD, PhD, Yunseon Choi MD, PhD, Geumju Park MD, PhD, Sunmi Jo MD, Sun Seong Lee MD, Jisun Park MD, Hye-Kyung Shim MD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 20 (2021)
Background and Aims: This study evaluated the prognostic value of 18 F-fluorodeoxyglucose positron emission tomography with integrated computed tomography ( 18 F-FDG PET/CT) performed before and after concurrent chemoradiotherapy (CCRT) in esophageal
Externí odkaz:
https://doaj.org/article/55e9883443ca40419a6e9b38b96afe46
Autor:
Sungmin Lee, Beomseok Son, Jaewan Jeon, Gaeul Park, Hyunwoo Kim, Hyunkoo Kang, HyeSook Youn, Sunmi Jo, Jie-Young Song, BuHyun Youn
Publikováno v:
Cellular Physiology and Biochemistry, Vol 47, Iss 6, Pp 2233-2249 (2018)
Background/Aims: Non-alcoholic fatty liver disease (NAFLD) is an emerging metabolic disease. Although it leads to severe hepatic diseases including steatohepatitis, cirrhosis, and hepatic cancer, little is known about therapy to prevent and cure hepa
Externí odkaz:
https://doaj.org/article/8e1f58381cb64c2d8ea3f61d666046e6
Autor:
Jaewan Jeon, Sungmin Lee, Hyunwoo Kim, Hyunkoo Kang, HyeSook Youn, Sunmi Jo, BuHyun Youn, Hae Yu Kim
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 10, p 5111 (2021)
Although there are many patients with brain tumors worldwide, there are numerous difficulties in overcoming brain tumors. Among brain tumors, glioblastoma, with a 5-year survival rate of 5.1%, is the most malignant. In addition to surgical operations
Externí odkaz:
https://doaj.org/article/7d4511f0ef624cc29dad34c4089d2b11
Autor:
Sang-Won Kim, Mison Chun, Sehwan Han, Yong Sik Jung, Jin Hyuk Choi, Seok Yun Kang, Hyunsoo Jang, Sunmi Jo
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0163748 (2016)
The role of postmastectomy radiotherapy in the treatment of T1-2 primary tumor with 1-3 positive lymph nodes is controversial. We compared treatment outcomes between breast conserving surgery followed by radiotherapy (BCS+RT) and total mastectomy alo
Externí odkaz:
https://doaj.org/article/1698ecd57d5b498db0f399486eedb7af
Autor:
Sunmi Jo1, Hye-kyung Shim2, Joo Yeon Kim3, Sang Kyun Bae2 sbae@inje.ac.kr, Mi Ra Kim4 enthns@naver.com
Publikováno v:
BioMed Research International. 11/22/2019, p1-11. 11p.
Publikováno v:
American Journal of Case Reports. 11/18/2019, Vol. 20, p1695-1698. 4p.
NRBF2-mediated autophagy contributes to metabolite replenishment and radioresistance in glioblastoma
Autor:
Jeongha Kim, Hyunkoo Kang, Beomseok Son, Min-Jung Kim, JiHoon Kang, Kang Hyun Park, Jaewan Jeon, Sunmi Jo, Hae Yu Kim, HyeSook Youn, BuHyun Youn
Publikováno v:
Experimentalmolecular medicine. 54(11)
Overcoming therapeutic resistance in glioblastoma (GBM) is an essential strategy for improving cancer therapy. However, cancer cells possess various evasion mechanisms, such as metabolic reprogramming, which promote cell survival and limit therapy. T
Publikováno v:
BioMed Research International, Vol 2019 (2019)
BioMed Research International
BioMed Research International
Myeloid sarcoma (MS) is a rarely encountered extramedullary localized tumor that is composed of immature myeloid cells. We reported an extremely rare case of MS with concurrent bone marrow (BM) involvement that invaded into a preexisting sebaceous ly